Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
KalVistakalvista.com · Low evidenceKalVista Pharmaceuticals is a biopharmaceutical company focused on developing orally delivered small molecule medicines for hereditary angioedema (HAE). The company aims to change the HAE treatment landscape by providing the first and only oral on-demand treatment option for patients.
Parse Score